Alsin (encoded by the ALS2 gene) is a 1849-amino acid protein with multiple functional domains that acts as a guanine nucleotide exchange factor (GEF) for small GTPases. It plays critical roles in endosomal trafficking, axonal outgrowth, and mitochondrial function. Recessive mutations in ALS2 cause juvenile-onset amyotrophic lateral sclerosis (ALS2) and infantile-onset ascending hereditary spastic paraplegia (AHSP).
| Alsin Protein (ALS2) |
|---|
| Protein Name | Alsin (ALS2) |
| Gene | [ALS2](/genes/als2) |
| UniProt ID | [Q96IT9](https://www.uniprot.org/uniprot/Q96IT9) |
| Molecular Weight | 184 kDa (full-length) |
| Subcellular Localization | Endosomes, Cytoplasm |
| Protein Family | GEF family, VPS9 domain proteins |
Alsin is a large protein with multiple functional domains:
flowchart TD
A["Alsin Protein 1849 aa"] --> B["RCC1-like Domain<br/>aa 1-500"]
A --> C["PH Domain<br/>aa 500-700"]
A --> D["VPS9 Domain<br/>aa 700-900"]
A --> E["MORN Repeat 1<br/>aa 900-1100"]
A --> F["MORN Repeat 2<br/>aa 1100-1300"]
A --> G["Proline-Rich Region<br/>aa 1300-1600"]
A --> H["C-terminal Domain<br/>aa 1600-1849"]
B --> I["GEF Activity for Rac1"]
C --> J["Membrane Targeting"]
D --> K["Rab5 Activation"]
E --> L["Phospholipid Binding"]
F --> M["Protein Interactions"]
¶ Domain Functions
| Domain |
Location |
Function |
| RCC1-like domain |
N-terminus |
Guanine nucleotide exchange factor activity for Rac1 |
| PH domain |
Central |
Membrane targeting and phosphoinositide binding |
| VPS9 domain |
Central |
Activates Rab5 for endocytic trafficking |
| MORN repeat domains |
Mid-region |
Membrane interaction and protein complex formation |
| Proline-rich region |
C-terminus |
Protein-protein interactions via SH3 domain binding |
Alsin is a multiunctional protein with several key cellular roles:
Alsin acts as a GEF for both Rab5 and Rac1, regulating early endosome function and cytoskeletal dynamics.
- Rab5 activation: Promotes early endosome fusion and trafficking
- Rac1 activation: Regulates actin cytoskeleton and membrane ruffling
- Endosomal maturation: Coordinates endosome-lysosome fusion
¶ Axonal Outgrowth and Neuronal Development
During development, alsin promotes:
- Neurite extension: Supports axonal growth cone formation
- Synapse formation: Facilitates dendritic spine development
- Axonal transport: Maintains microtubule-based transport
Alsin helps maintain mitochondrial integrity through:
- Mitochondrial dynamics: Regulates fission and fusion
- Mitochondrial trafficking: Supports axonal transport of mitochondria
- Cell survival: Protects against apoptotic stimuli
Alsin participates in autophagy regulation by modulating:
- Autophagosome formation: Coordinates with ULK1 complex
- Late autophagic trafficking: Affects lysosomal fusion
- Selective mitophagy: May interact with PINK1/PARKIN pathway
Recessive loss-of-function mutations in ALS2 cause juvenile-onset ALS.
Pathogenic mutations include:
- Q864X: Premature stop codon
- E542fs: Frameshift truncation
- A252V: Missense mutation in VPS9 domain
- Large deletions: Genomic rearrangements
Disease mechanism:
- Loss of alsin GEF function
- Impaired Rab5-mediated endosomal trafficking
- Defective axonal maintenance and transport
- Accumulation of damaged organelles
- Progressive motor neuron degeneration
Similar ALS2 mutations cause AHSP, characterized by:
- Progressive spasticity in lower limbs
- Motor neuron dysfunction
- Early onset in infancy or childhood
Alsin dysfunction may contribute to:
- Sporadic ALS: Endosomal trafficking defects common to multiple forms
- Frontotemporal dementia: Cytoskeletal dysfunction
- Parkinson's Disease: Potential mitochondrial interactions
Studies in Als2-deficient mice have revealed:
- Age-dependent motor impairment
- Accumulation of vacuoles in motor neurons
- Mitochondrial abnormalities
- Sensitivity to oxidative stress
- Impaired endosomal trafficking
- Morpholino knockdown causes motor axon defects
- Rescue by human ALS2 expression
- Reveals developmental role in motor neuron pathfinding
- AAV-delivered wild-type ALS2: Restore alsin function
- CRISPR-mediated correction: Repair pathogenic mutations
- Allele-independent expression: Deliver functional ALS2
- Rab5 modulators: Enhance endosomal trafficking
- Rac1 activators: Compensate for lost GEF function
- Neurotrophic factors: BDNF, GDNF delivery
- Riluzole: FDA-approved ALS drug
- Edaravone: Antioxidant therapy
- Physical therapy: Maintain function
- Respiratory support: For disease progression
flowchart LR
A["Alsin"] --> B["Rab5 GEF"]
A --> C["Rac1 GEF"]
B --> D["Early Endosomes"]
D --> E["Endosomal Maturation"]
E --> F["Autophagosome Formation"]
C --> G["Actin Cytoskeleton"]
G --> H["Membrane Ruffling"]
H --> I["Axonal Growth"]
J["Mitochondrial Quality Control"] --> K["Cell Survival"]
subgraph ALS2 Loss
L["Rab5 Inactivation"] --> M["Endosomal Dysfunction"]
N["Rac1 Inactivation"] --> O["Cytoskeletal Defects"]
M --> P["Motor Neuron Degeneration"]
O --> P
end